Personalis (PSNL) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estima

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for

MONSEY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Monsey law firm of Wohl & Fruchter LLP is invest

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a nationally recognized shareholde

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

BALA CYNWYD, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full de

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

NEW YORK, July 21, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & As

BALA CYNWYD, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi

Personalis, Inc. (PSNL) M&A Call Transcript

Tempus AI stock has fallen about 16% YTD. Cathie Wood still owns it as ARKK's 4th largest holdin

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

Lake Street analyst Thomas Flaten downgrades Personalis (NASDAQ:PSNL) from Buy to Hold and announ

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price targ

Tempus AI stock falls after a $1.5 billion Personalis deal expands its reach in the $20 billion MRD

Tempus AI NASDAQ: TEM executives said the company's planned acquisition of Personalis is intended to

Shareholder Alert: Ademi LLP investigates whether Personalis, Inc. is obtaining a Fair Price for Pub

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a nationally recognized shareholde

MILWAUKEE, July 20, 2026 /PRNewswire/ -- Ademi LLP is investigating Personalis (NASDAQ: PSNL) for po

Tempus AI pledged to buy cancer diagnostics outfit Personalis for $1.5 billion on Monday. But shares

Acquisition brings together Personalis’ MRD technology with Tempus’ commercial scale, multimodal dat

Needham analyst Mike Matson maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price ta

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

This critical regulatory milestone enables the clinical use of Personalis’ ultrasensitive Minimal Re

Morgan Stanley analyst Tejas Savant maintains Personalis (NASDAQ:PSNL) with a Equal-Weight and ra

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

  On Tuesday, 456 stocks hit new 52-week lows.

  On Tuesday, 400 companies set new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Thursday